Aperta Biosciences LLC
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.
Phase 2
Not yet recruiting
- Conditions
- Blepharitis
- Interventions
- Drug: APT-001 topical ophthalmic ointment (spinosad)Drug: Vehicle control for APT-001 topical ophthalmic ointment
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Aperta Biosciences, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT06720896
- Locations
- 🇬🇹
Dr. Rudy Gutierrez Diaz Sede Central, Guatemala City, Guatemala
News
No news found